Healthcare - Biotechnology - NASDAQ - US
$ 0.255
-3.85 %
$ 6.61 M
Market Cap
-0.64
P/E
CASH FLOW STATEMENT
-5.67 M
OPERATING CASH FLOW
-794 K
INVESTING CASH FLOW
3.63 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Cardio Diagnostics Holdings, Inc.
| Net Income | -8.38 M |
| Depreciation & Amortization | 112 K |
| Capital Expenditures | -773 K |
| Stock-Based Compensation | 1.28 M |
| Change in Working Capital | 209 K |
| Others | 2.1 M |
| Free Cash Flow | -6.45 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| OPERATING CASH FLOW | ||||
| Net Income | (8.4) | (4.7) | (0.6) | (0.6) |
| Depreciation & Amortization | 0.1 | 16 K | 16 K | 10.7 K |
| Deferred Income Tax | 0 | 0 | 0 | 39.2 K |
| Stock Based Compensation | 1.3 | 0 | 60 K | 0.6 |
| Other Operating Activities | 1.1 | 0.1 | 3.28 K | 39.2 K |
| Change in Working Capital | 0.2 | (0.6) | 37.6 K | 31.1 K |
| Cash From Operations | (5.7) | (5.1) | (0.6) | 25.9 K |
| INVESTING CASH FLOW | ||||
| Capital Expenditures | (0.8) | 76.2 K | (0.1) | 29.9 K |
| Other Items | 21.4 K | (0.3) | (0.2) | 0 |
| Cash From Investing Activities | (0.8) | (0.4) | (0.4) | 29.9 K |
| FINANCING CASH FLOW | ||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 3.6 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 75 K | (2.9) | 0.1 | 0.2 |
| Cash From Financing Activities | 3.6 | 9.1 | 1.2 | 0.2 |
| CHANGE IN CASH | ||||
| Net Change In Cash | (2.8) | 3.6 | 0.3 | 0.2 |
| FREE CASH FLOW | ||||
| Free Cash Flow | (6.4) | (5.2) | (0.7) | 4.05 K |